http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101254299-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62873d8ad6d1eb30128a59941cec0a7c |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate | 2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-101254299-A |
titleOfInvention | Therapy of diabetic under bark dysfunction |
abstract | The invention relates to a method for treating the endothelial dysfunction of a patient with diabetes, the dysfunction includes the diabetes-induced giant vascular disease and the diabetes-induced micro-vascular disease, the treatment method includes the application of an effective amount of high-density lipoprotein (HDL) on the patient, and the parenteral administration is preferential. |
priorityDate | 2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 217.